TipRanks
Go Ultimate55% OFF

STRATEC Biomedical (SBS) Revenue

STRATEC Biomedical Revenue

STRATEC Biomedical had a revenue of 59.11M in the quarter ending Jun 30, 2026, with 10.64%. This bring the company's revenue in the last twelve months to 244.81M, Decreased 0.08%. In the fiscal year ending Mar 31, 2026, STRATEC Biomedical had annual revenue of 250.86M with -2.62% growth.

Revenue (ttm)
244.81M
Revenue Growth
―
P/S Ratio
1.09
Revenue/Employee
EUR 181,390
Employees
1,383
Market Cap
EUR 273.51M

Revenue Chart

STRATEC Biomedical Revenue - Annual

050M100M150M200M250M300M350M209.76M187.82M221.64M250.10M287.33M274.63M270.41M257.62M250.86M201720192020202120212022202320252026
Revenue History
Download to Excel
DE:SBS revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 2026250.86M-6.76M-2.62%
Mar 31, 2025257.62M-12.79M-4.73%
Dec 31, 2023270.41M-4.21M-1.53%
Dec 31, 2022274.63M-12.71M-4.42%
Dec 31, 2021287.33M37.24M14.89%
Mar 31, 2021250.10M28.46M12.84%
Mar 31, 2020221.64M33.82M18.01%
Mar 31, 2019187.82M-21.95M-10.46%
Dec 31, 2017209.76M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:SBS244.81M
DE:DRW83.59B
DE:EUZ312.54M
DE:SIS113.82M
DE:GXI2.28B
DE:SHL23.17B